Spontaneous tibiotalar arthrodesis as a complication of acute tibial osteomyelitis due to Panton-Valentine leukocidin-producing Staphylococcus aureus: a case report
© Ceroni et al.; licensee BioMed Central Ltd. 2012
Received: 25 February 2012
Accepted: 15 May 2012
Published: 17 July 2012
Strains of Panton-Valentine leukocidin-producing Staphylococcus aureus producing a new pattern of disease have emerged worldwide. Infection with these bacteria typically presents as a life-threatening infection of soft tissues and bones, and may cause potentially devastating consequences.
We report a case of osteoarticular infection caused by Panton-Valentine leukocidin-producing Staphylococcus aureus. A 12-year-old Caucasian girl presented with acute osteomyelitis of the tibia associated with toxic shock syndrome, which was complicated by an unexpected spontaneous ankle arthrodesis.
Osteoarticular infections due to Panton-Valentine leukocidin-producing Staphylococcus aureus appear to be severe, and are characterized by their tendency to evolve towards serious complications. This case highlights the need for early and aggressive surgical procedures in conjunction with appropriate antimicrobial therapy and regular long-term follow-up.
Panton-Valentine leukocidin (PVL) is a pore-forming toxin , secreted by 2% to 5% of Staphylococcus aureus strains. This exotoxin induces polymorphonuclear cell death via necrosis or apoptosis, and the subsequent release of leukocytic cytokines . Induction of leukocyte apoptosis by S. aureus may cause extensive tissue necrosis and compromise the antimicrobial response, thereby facilitating bacterial spread . The presence of PVL genes is associated with an increased risk of more severe systemic inflammation and serious infection requiring intensive care [3, 4]. PVL-positive staphylococcal infections may lead to life-threatening infections of soft tissues, such as necrotizing hemorrhagic pneumonia, associated with a high mortality rate [5–7]. Bone and joint infections with PVL-producing S. aureus (PVL + SA) are more aggressive, present a different evolution, and have a probably higher rate of orthopedic complications . The purpose of this paper is to report an unusual and severe complication resulting from an osteoarticular infection of PVL + SA.
A previously healthy 12-year-old Caucasian girl was brought to the emergency department of our hospital complaining of a swollen left ankle and fever. She had a history of ankle trauma three days before. Her vital signs included a temperature of 40°C, a pulse rate of 132 beats/minute, a respiratory rate of 22 breaths/minute and blood pressure of 90/55 mmHg. Her left leg and ankle were diffusely tender. There was redness on her foot and the medial aspect of her leg. Laboratory results showed a white blood cell count of 21,000 cells/mm3, an elevated C-reactive protein (200 mg/dL; reference range: 0 to 10 mg/dL) and an abnormal erythrocyte sedimentation rate (78 mm/h).
PVL is an exotoxin that induces cytotoxic and cytolytic changes in leukocytes. Complications of infections with PVL + SA include septic thrombosis, purpura fulminans and a redoubtable necrotizing pneumonia . Clinical and biological signs of pulmonary disease are characterized by a combination of hemoptysis, multilobar alveolar infiltrations and leukopenia . Severe pulmonary infection with PVL + SA has a mortality rate up to 75% despite intensive medical care . In those cases, intensive care, antibiotics, aggressive surgical treatment and the additional application of immunoglobulins is the recommended treatment . It is nevertheless important to keep in mind that the onset of necrotizing pneumonia may happen during the evolution of osteoarticular infection.
Interest in PVL + SA has progressively increased over the last years, probably due to the continuing improvement of PVL + SA detection methods with novel PCR assays. However, to date, only a few papers have focused specifically on the aspect of bone and joint infections [7–9, 11–13]. The true incidence of osteoarticular infections caused by PVL + SA is unknown, probably because the number of infections due to this strain is underestimated. Ellington et al. found that only 1.6% of S. aureus from patients with bacteremia in the UK were PVL-positive . In the USA, the PVL-positive methicillin-resistant S. aureus (MRSA) strain is responsible for 20% of bloodstream infections , and in Germany, PVL + SA became the second most frequent MRSA isolate . In our department, we noted only two cases of osteoarticular infections due to PVL + SA.
From an orthopedic point of view, the emergence of osteoarticular infections due to PVL + SA has complicated the conventional management of these infections in children . PVL + SA infections of bone and joints induce more often a concomittant myositis or pyomyositis than PVL negative SA infections . Furthermore, the bone infections are more severe, presenting extended diaphysitis and bone abscesses, and causing more complications .
Therefore, osteoarticular infections due to such strains need longer antibiotic courses and various surgical procedures [8, 15]. In children, orthopedic consequences may arise if the growth cartilage is involved, or if the articular cartilage is damaged by the infection; unfortunately the early diagnosis of these sequelae is often difficult.
In our case, our patient sustained an unusual complication because joint arthrodesis is not commonly encountered after PVL + SA infections. Nevertheless, the biological characteristics of PVL + SA may explain, from a theoretical point of view, the onset of spontaneous arthrodesis after an osteoarticular infection. In fact, PVL specifically interacts with and lyses polymorphonuclear leukocytes, and thus contributes to the inhibition of infection clearance by the host immune system, thereby enabling staphylococcal species to persist . If the infection is not quickly cleared by the host, the potent activation of the immune response, in association with high levels of cytokines and reactive oxygen species, increase the release of host matrix metalloproteinases and other collagen-degrading enzymes, which in conjunction with bacterial toxins lead to joint destruction . The polymorphonuclear response with subsequent release of these proteolytic enzymes can lead to permanent destruction of the intra-articular cartilage and subchondral bone loss in as little as three days . In addition, metalloproteinases and the antigen-induced inflammatory response may persist and continue to damage the joint architecture even after the infection has been cleared [18–20].
PVL + SA seems to be an emerging and dangerous pathogen of osteoarticular infections in children. Its evolution is more aggressive, treatment more difficult, and complications more severe. Even if infections caused by PVL + SA are currently still uncommon, a PCR-based assay for toxin gene profiling should be performed in cases of severe and extended osteoarticular infections or when severe sepsis occurs. Orthopedic surgeons must be aware of the possible future changes in the evolution and behavior of osteoarticular infections in children. There is probably a subtle balance between an effective immune response, which eliminates the infecting organism from the host, and the overactivation of this response that causes the majority of infection-related joint destruction. For this reason, it is now unanimously recognized that a surgical approach is mandatory for the management of PVL + SA osteoarticular infections, in conjunction with an appropriate antimicrobial therapy, and long-term follow-up of the affected children is necessary to recognize late-onset sequelae.
Written informed consent was obtained from the patient’s legal guardian for publication of this manuscript and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Panton P, Valentine F: Staphylococcal toxin. Lancet. 1932, 1: 506-508.View ArticleGoogle Scholar
- Genestier AL, Michallet MC, Prevost G, Bellot G, Chalabreysse L, Peyrol S, Thivolet F, Etienne J, Lina G, Vallette FM, Vandenesch F, Genestier L: Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest. 2005, 115: 3117-3127. 10.1172/JCI22684.View ArticlePubMedPubMed CentralGoogle Scholar
- Bocchini CE, Hulten KG, Mason EO, Gonzalez BE, Hammerman WA, Kaplan SL: Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006, 117: 433-440. 10.1542/peds.2005-0566.View ArticlePubMedGoogle Scholar
- Sdougkos G, Chini V, Papanastasiou DA, Christodoulou G, Tagaris G, Dimitracopoulos G, Spiliopoulou I: Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin as a cause of acute osteomyelitis in children. Clin Microbiol Infect. 2007, 13: 651-654. 10.1111/j.1469-0691.2007.01713.x.View ArticlePubMedGoogle Scholar
- Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piémont Y, Brousse N, Floret D, Etienne J: Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002, 359: 753-759. 10.1016/S0140-6736(02)07877-7.View ArticlePubMedGoogle Scholar
- Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM: Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol. 2005, 43: 2384-2390. 10.1128/JCM.43.5.2384-2390.2005.View ArticlePubMedPubMed CentralGoogle Scholar
- Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J: Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999, 29: 1128-1132. 10.1086/313461.View ArticlePubMedGoogle Scholar
- Moumile K, Cadilhac C, Lina G, Berche P, Glorion C, Ferroni A: Severe osteoarticular infection associated with Panton-Valentine leukocidin-producing Staphylococcus aureus. Diagn Microbiol Infect Dis. 2006, 56: 95-97. 10.1016/j.diagmicrobio.2006.03.007.View ArticlePubMedGoogle Scholar
- Mitchell PD, Hunt DM, Lyall H, Nolan M, Tudor-Williams G: Panton-Valentine leukocidin-secreting Staphylococcus aureus causing severe musculoskeletal sepsis in children. A new threat. J Bone Joint Surg Br. 2007, 89: 1239-1242. 10.1302/0301-620X.89B9.19485.View ArticlePubMedGoogle Scholar
- Salliot C, Zeller V, Puechal X, Manceron V, Sire S, Varache N, Etienne J, Desplaces N, Ziza JM: Panton-Valentine leukocidin-producing Staphylococcus aureus infections: report of 4 French cases. Scand J Infect Dis. 2006, 38: 192-195. 10.1080/00365540500388776.View ArticlePubMedGoogle Scholar
- Dohin B, Gillet Y, Kohler R, Lina G, Vandenesch F, Vanhems P, Floret D, Etienne J: Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J. 2007, 26: 1042-1048. 10.1097/INF.0b013e318133a85e.View ArticlePubMedGoogle Scholar
- Ellington MJ, Hope R, Ganner M, Ganner M, East C, Brick G, Kearns AM: Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK?. J Antimicrob Chemother. 2007, 60: 402-405. 10.1093/jac/dkm206.View ArticlePubMedGoogle Scholar
- van Duijkeren E, Wolfhagen MJ, Heck ME, Wannet WJ: Transmission of a Panton-Valentine leucocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog. J Clin Microbiol. 2005, 43: 6209-6211. 10.1128/JCM.43.12.6209-6211.2005.View ArticlePubMedPubMed CentralGoogle Scholar
- Witte W, Strommenger B, Cuny C, Heuck D, Nuebel U: Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother. 2007, 60: 1258-1263. 10.1093/jac/dkm384.View ArticlePubMedGoogle Scholar
- Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO, Kaplan SL: Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004, 23: 701-706. 10.1097/01.inf.0000133044.79130.2a.View ArticlePubMedGoogle Scholar
- Shirtliff ME, Mader JT: Acute septic arthritis. Clin Microbiol Rev. 2002, 15: 527-544. 10.1128/CMR.15.4.527-544.2002.View ArticlePubMedPubMed CentralGoogle Scholar
- Roy S, Bhawan J: Ultrastructure of articular cartilage in pyogenic arthritis. Arch Pathol. 1975, 99: 44-47.PubMedGoogle Scholar
- Riegels-Nielsen P, Frimodt-Moller N, Sorensen M, Jensen JS: Antibiotic treatment insufficient for established septic arthritis. Staphylococcus aureus experiments in rabbits. Acta Orthop Scand. 1989, 60: 113-115. 10.3109/17453678909150107.View ArticlePubMedGoogle Scholar
- Smith RL, Schurman DJ: Bacterial arthritis. A staphylococcal proteoglycan-releasing factor. Arthritis Rheum. 1986, 29: 1378-1386. 10.1002/art.1780291111.View ArticlePubMedGoogle Scholar
- Smith RL, Schurman DJ, Kajiyama G, Mell M, Gilkerson E: The effect of antibiotics on the destruction of cartilage in experimental infectious arthritis. J Bone Joint Surg Am. 1987, 69: 1063-1068.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.